首页> 外国专利> EVALUATION OF METHOD OF INHIBITING ACTIVITY OF ADENYLATE CYCLASE IN ERYTHROCYTE MEMBRANES IN AGGRAVATED CYTOMEGALOVIRUS INFECTION IN PREGNANT WOMEN IN THIRD TRIMESTER OF GESTATION

EVALUATION OF METHOD OF INHIBITING ACTIVITY OF ADENYLATE CYCLASE IN ERYTHROCYTE MEMBRANES IN AGGRAVATED CYTOMEGALOVIRUS INFECTION IN PREGNANT WOMEN IN THIRD TRIMESTER OF GESTATION

机译:妊娠第三代孕妇子宫肌球蛋白感染的红细胞膜抑制腺苷酸环化酶活性的方法评价

摘要

FIELD: medicine.SUBSTANCE: invention refers to medicine and can be used for assessing the threat of hemic anaemia among pregnant women in the third trimester of gestation in case of acute cytomegaloviral infection. Method involves measuring in erythrocyte membranes of the cytomegalovirus antibody titre, content of activity of adenylate cyclase in peripheral blood erythrocytes and ATP. If cytomegalovirus antibody titre is 1:1,600 and there is noted a reduction of content in peripheral blood of erythrocytes with activity of adenylate cyclase up to 10.0 ± 0.2 %, ATP - up to 0.52 ± 0.04 mmol/ml and oxyhaemoglobin - up to 96.3 ± 1.7 %, the risk of a pregnant woman hemic anaemia shall be estimated.EFFECT: estimation of hemic anaemia risk for pregnant women in the third trimester of gestation in case of an acute cytomegaloviral infection.1 cl, 2 dwg
机译:领域:药物。发明:本发明是指药物,可用于评估妊娠晚期妊娠中急性巨细胞病毒感染的孕妇中贫血的威胁。方法包括测量红细胞膜中巨细胞病毒抗体的滴度,外周血红细胞中腺苷酸环化酶活性和ATP的含量。如果巨细胞病毒抗体滴度为1:1,600,并且注意到外周血中红细胞含量降低,则腺苷酸环化酶的活性最高可达10.0±0.2%,ATP-最高可达0.52±0.04 mmol / ml,氧合血红蛋白-最高可达96.3± 1.7%,应估计孕妇发生血液性贫血的风险效果:在妊娠晚期,如果发生急性巨细胞病毒感染,应评估孕妇的血液性贫血的风险1 cl,2 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号